购物车
- 全部删除
- 您的购物车当前为空
AKOS037652256可作为 TRPML 调节剂,可用于治疗如溶酶体积存病、肌肉萎缩症、与年龄相关的常见神经退行性疾病、氧化应激或活性氧(ROS)相关疾病以及衰老等与 TRPML 活性相关的疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
AKOS037652256可作为 TRPML 调节剂,可用于治疗如溶酶体积存病、肌肉萎缩症、与年龄相关的常见神经退行性疾病、氧化应激或活性氧(ROS)相关疾病以及衰老等与 TRPML 活性相关的疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,300 | 现货 | |
5 mg | ¥ 2,900 | 现货 | |
10 mg | ¥ 4,290 | 现货 | |
25 mg | ¥ 6,850 | 现货 | |
50 mg | ¥ 9,270 | 现货 | |
100 mg | ¥ 12,500 | 现货 |
产品描述 | AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing. |
靶点活性 | TRPML:< = 2 µM(AC50), TRPML1:< = 2 µM(AC50) |
体外活性 | AKOS037652256(0.1-3 μM)足以诱导TFEB向核内转移(核/细胞质比例随剂量增加而上升)。[2] |
分子量 | 553.07 |
分子式 | C24H26ClFN4O4S2 |
CAS No. | 2171065-77-1 |
Smiles | CN(C)S(=O)(=O)c1ccc(cc1)S(=O)(=O)Nc1ccccc1N1CCN(CC1)c1ccc(Cl)cc1F |
存储 | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 5.53 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容